Holen Sie sich die Stockscreener-App
5.4927
0.13%
-0.0073
Schlusskurs vom Vortag:
$5.50
Offen:
$5.35
24-Stunden-Volumen:
4,370
Relative Volume:
0.26
Marktkapitalisierung:
$49.40M
Einnahmen:
$23.84M
Nettoeinkommen (Verlust:
$-3.81M
KGV:
-10.99
EPS:
-0.5
Netto-Cashflow:
$-713.00K
1W Leistung:
-0.13%
1M Leistung:
+11.87%
6M Leistung:
+54.72%
1J Leistung:
+9.42%
1-Tages-Spanne:
$5.35
$5.51
1-Wochen-Bereich:
$5.20
$5.55
52-Wochen-Spanne:
$3.34
$5.82
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Vergleichen Sie ICCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
5.435 | 49.40M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.97 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.78 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.45 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.10 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.81 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell reports record sales in first quarter of 2025 - Investing.com
Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan
ImmuCell appoints new CFO to bolster growth strategy - Investing.com
ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan
ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance
Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan
IMMUCELL CORP /DE/ SEC 10-K Report - TradingView
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
ImmuCell Corp. to Host Earnings Call - ACCESS Newswire
ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval For Re-Tain - Barchart
ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... By GuruFocus - Investing.com Canada
ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell sees strong Q4 2024 sales growth - Investing.com
ImmuCell Corporation Reports Strong Financial Performance for Q4 and Full Year 2024 - TradingView
Animal Health Pioneer ImmuCell Sets Stage for Critical Year-End Financial Reveal - StockTitan
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance
Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell Settles Insurance Claim for Production Contamination Events - Defense World
ImmuCell settles insurance claim for production losses - Investing.com
ImmuCell Secures $426,587 Additional Insurance Settlement for Production Contamination Issues - StockTitan
ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024 - Defense World
ImmuCell Sales Surge 52% to Record $26.5M as Production Hits Full Capacity - StockTitan
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
ImmuCell announces executive transition with part-time agreement By Investing.com - Investing.com South Africa
ImmuCell announces executive transition with part-time agreement - Investing.com
Zacks Initiates Coverage of ImmuCell With Neutral Recommendation - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell - Yahoo Finance
Top Research Reports for Amazon, Stryker & Lam Research - Yahoo Finance
ImmuCell amends agreement with Norbrook Labs - Investing.com
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports recovery and strong demand for Q3 2024 - Investing.com
ICCCImmucell Corp Latest Stock News & Market Updates - StockTitan
ImmuCell Q3 Sales Jump 11% to $6M, Nine-Month Revenue Surges 51% Despite Net Loss | ICCC Stock News - StockTitan
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - StockTitan
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - StockTitan
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023) - Yahoo Finance
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - StockTitan
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):